Prevalence of cardio-metabolic syndrome in Nigeria

A systematic review

V. M. Oguoma, E. U. Nwose, R. S. Richards

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1%) adopted the WHO classification, 19 (59.4%) used the ATPIII definition, while the remaining 10 (31.3%) studies used the IDF definitions. Twenty (62.5%) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5%) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7%, 27.9% and 28.1% according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.

Original languageEnglish
Pages (from-to)413-423
Number of pages11
JournalPublic Health
Volume129
Issue number5
DOIs
Publication statusPublished - 1 May 2015
Externally publishedYes

Fingerprint

Nigeria
Population
National Heart, Lung, and Blood Institute (U.S.)
Rural Population
PubMed
Insulin Resistance
Life Style
Young Adult
Consensus
Thyroid Gland
Age Groups
Cholesterol
HIV
Databases
Education

Cite this

Oguoma, V. M. ; Nwose, E. U. ; Richards, R. S. / Prevalence of cardio-metabolic syndrome in Nigeria : A systematic review. In: Public Health. 2015 ; Vol. 129, No. 5. pp. 413-423.
@article{5c0a00b413fa4275a08b566d8587bdd6,
title = "Prevalence of cardio-metabolic syndrome in Nigeria: A systematic review",
abstract = "Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1{\%}) adopted the WHO classification, 19 (59.4{\%}) used the ATPIII definition, while the remaining 10 (31.3{\%}) studies used the IDF definitions. Twenty (62.5{\%}) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5{\%}) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7{\%}, 27.9{\%} and 28.1{\%} according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.",
keywords = "ATPIII, Cardiometabolic syndrome, IDF, Nigeria, Prevalence, WHO",
author = "Oguoma, {V. M.} and Nwose, {E. U.} and Richards, {R. S.}",
note = "Crown Copyright {\circledC} 2015. Published by Elsevier Ltd. All rights reserved.",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.puhe.2015.01.017",
language = "English",
volume = "129",
pages = "413--423",
journal = "Public Health",
issn = "0033-3506",
publisher = "Elsevier",
number = "5",

}

Prevalence of cardio-metabolic syndrome in Nigeria : A systematic review. / Oguoma, V. M.; Nwose, E. U.; Richards, R. S.

In: Public Health, Vol. 129, No. 5, 01.05.2015, p. 413-423.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prevalence of cardio-metabolic syndrome in Nigeria

T2 - A systematic review

AU - Oguoma, V. M.

AU - Nwose, E. U.

AU - Richards, R. S.

N1 - Crown Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1%) adopted the WHO classification, 19 (59.4%) used the ATPIII definition, while the remaining 10 (31.3%) studies used the IDF definitions. Twenty (62.5%) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5%) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7%, 27.9% and 28.1% according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.

AB - Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1%) adopted the WHO classification, 19 (59.4%) used the ATPIII definition, while the remaining 10 (31.3%) studies used the IDF definitions. Twenty (62.5%) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5%) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7%, 27.9% and 28.1% according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.

KW - ATPIII

KW - Cardiometabolic syndrome

KW - IDF

KW - Nigeria

KW - Prevalence

KW - WHO

UR - http://www.scopus.com/inward/record.url?scp=84930276746&partnerID=8YFLogxK

UR - http://www.mendeley.com/catalogue/prevalence-cardiometabolic-syndrome-nigeria-systematic-review

U2 - 10.1016/j.puhe.2015.01.017

DO - 10.1016/j.puhe.2015.01.017

M3 - Review article

VL - 129

SP - 413

EP - 423

JO - Public Health

JF - Public Health

SN - 0033-3506

IS - 5

ER -